Literature DB >> 7474001

Neurogenic pulmonary edema in fatal and nonfatal head injuries.

F B Rogers1, S R Shackford, G T Trevisani, J W Davis, R C Mackersie, D B Hoyt.   

Abstract

Impaired pulmonary function is a frequent but poorly understood complication of acute head injury (HI). A potential early contributor to the pulmonary dysfunction seen in HI patients is neurogenic pulmonary edema (NPE). We hypothesized that NPE would occur early after HI and that it would have a continuum of clinical severity depending on the severity of the HI and associated intracranial hypertension. A large autopsy data base and inpatient HI data base were used to search for cases of NPE. Patients in the autopsy data base were stratified according to injury type and whether they died at the scene or within 96 hours of injury. There were significant (p < 0.0001, analysis of variance) elevations in lung weights in patients dying at the scene and within 96 hours from HI, compared with those dying from other noncentral nervous system injuries. No other organs studied showed significant weight increases. The incidence of NPE in isolated HI patients dying at the scene was 32%. In patients with isolated HI dying within 96 hours, the incidence of NPE was 50%. We found an inverse correlation (r = 0.62; p < 0.0014) between the initial cerebral perfusion pressure and the PaO2/FIO2 ratio despite a normal-appearing chest x-ray film. We conclude that NPE occurs frequently in HI patients. The process of edema formation begins early in the clinical course and is isolated to the lung.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7474001     DOI: 10.1097/00005373-199511000-00009

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  29 in total

Review 1.  Article 8. An introduction to hypothesis testing. Non-parametric comparison of two groups-1.

Authors:  P Driscoll; F Lecky
Journal:  Emerg Med J       Date:  2001-07       Impact factor: 2.740

Review 2.  General medical care on the neuromedical intensive care unit.

Authors:  Robin S Howard; Jeremy Radcliffe; Nicholas P Hirsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 3.  Brain-lung crosstalk: Implications for neurocritical care patients.

Authors:  Ségolène Mrozek; Jean-Michel Constantin; Thomas Geeraerts
Journal:  World J Crit Care Med       Date:  2015-08-04

Review 4.  Respiratory mechanics in brain injury: A review.

Authors:  Antonia Koutsoukou; Maria Katsiari; Stylianos E Orfanos; Anastasia Kotanidou; Maria Daganou; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Nikoletta Rovina
Journal:  World J Crit Care Med       Date:  2016-02-04

5.  Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) as a Source of Lungs for Transplant.

Authors:  T M Egan; J J Requard
Journal:  Am J Transplant       Date:  2015-04-14       Impact factor: 8.086

Review 6.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

7.  Ventilatory setting in severe brain injured patients: does it really matter?

Authors:  Luciana Mascia
Journal:  Intensive Care Med       Date:  2006-10-20       Impact factor: 17.440

8.  Neurogenic pulmonary edema during intracranial endovascular therapy.

Authors:  Randall P Brewer; Cecil O Borel
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

9.  Role of PiCCO monitoring for the integrated management of neurogenic pulmonary edema following traumatic brain injury: A case report and literature review.

Authors:  Xiaoping Lin; Zhijun Xu; Pengfei Wang; Yan Xu; Gensheng Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

10.  Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.

Authors:  Hideki Yasui; Deborah L Donahue; Mark Walsh; Francis J Castellino; Victoria A Ploplis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.